Dr. Beth A. Moore, MD

Dr. Moore practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Moore's NPI, 1720139488, was assigned on January 16, 2007. Dr. Moore graduated from Lewis Katz School of Medicine in 1991. Dr. Moore holds California license G83667.

Dr. Moore's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Moore's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dmand AI also links Dr. Moore to 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moore practices, 3 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Moore's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Moore is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Moore's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Moore treats.

CMS data shows 2,318 Medicare services from Dr. Moore across 10 procedure codes in 2024, for 1,171 Medicare patients. Medicare paid $284,462 for them.

CMS counts 1,171 Medicare patients who saw Dr. Moore in 2024. The largest group is 65 to 74, with 489 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moore's median patient age at 64, with 58% women.

In 2024, Dr. Moore wrote 572 Medicare Part D claims for 419 patients. 80% of them were for generic drugs. CMS names the drug for 469 of them, across 7 drugs with 11 or more claims each, at $28,311 in total drug cost. In 2023, CMS named 407 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Moore for performance year 2024, reported individually. Dr. Moore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moore as offering telehealth. CMS counts 258 procedures of colonoscopy by Dr. Moore, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Moore in 2016.

Dmand AI links Dr. Moore to 1 clinical trial. Conditions studied include Rectal Fistula and Intestinal Fistula.

CMS Open Payments shows 225 general payments to Dr. Moore from 37 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 57% of the total. Intuitive Surgical, Inc. paid the most, $5,831.

Dmand AI lists 8 awards for Dr. Moore, most recently Super Doc in 2013.

Dr. Moore graduated from Lewis Katz School of Medicine in 1991. Dr. Moore is a member of ACS.

Dr. Moore is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.